Switch to:
More From Other Websites
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend Dec 17 2014
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend Dec 17 2014
Amgen Leukemia Treatment to Cost $178,000, Among Priciest Drugs Dec 17 2014
Exclusive - Amgen's new leukemia drug to carry $178,000 price tag Dec 17 2014
Exclusive - Amgen's new leukemia drug to carry $178,000 price tag Dec 17 2014
Where is Santa rally? Dec 15 2014
Is This The Future Of Late-Stage Drug Development? Dec 15 2014
Biotech Entrepreneur Tony Coles Takes Aim At Parkinson's And Alzheimer's Dec 15 2014
Meet 5 Top Biotech Stocks Holding Up In Shaky Market Dec 13 2014
How Can Drugmakers Handle New Pricing Pressures? Dec 11 2014
AstraZeneca and Amgen to present detailed results from Phase III AMAGINE-1™ study evaluating... Dec 11 2014
Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In... Dec 11 2014
Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In... Dec 11 2014
How Amgen Makes Billions On Just A Few Drugs Dec 11 2014
Equity markets fell…and fell hard (no recovery like yesterday) Dec 10 2014
Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data Dec 10 2014
Amgen Successfully Expands Xgeva Label in the U.S. Dec 09 2014
Big-Cap Stock Funds Tend To Lag Dec 09 2014
Amgen Presents Data From Pivotal Phase 2 Study Of BLINCYTO™ (blinatumomab) Immunotherapy In... Dec 08 2014
Amgen Unveils Positive Results from Blood Cancer Studies Dec 08 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK